Company profile
Clearmind Medicine Inc.
NASDAQ: CMND · Healthcare · Biotechnology
Canadian filerHQ Vancouver, BCCIK 0001892500Reports USD
#1 of 1,418 Healthcare companies by revenue
EA Score
——FH 38DQ —GM —SS 20
v0.1 · 35/100 weight · pillars only
↑ Altman-Z, Piotroski F · ↓ listing tenure, return on equity
Methodology →Revenue TTM
$0
Rev growth YoY (TTM)
needs 8 qtrs
Net income (FY)
-$3.9M
Employees
4
as of 2026-08-25
Market cap
$2.5M
as of 2026-08-25
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Net income-$3.9M-$3.9M2025
Total assets$6.1M$6.1M2025
Liabilities$4.9M$4.9M2025
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Clearmind Medicine Inc.’s financial profile?
Clearmind Medicine Inc. earned -$3.9M in FY2025 net income.
Peers · Healthcare
Strainsforpains, Inc.——Accustem Sciences Inc.——Avricore Health Inc.——Endovia Health Sciences, Inc.——Artelo Biosciences, Inc.——Restart Life Sciences Corp.——Key facts
CEOAdi Zuloff-Shani
SectorHealthcare
IndustryBiotechnology
HeadquartersVancouver, BC
ExchangeNASDAQ: CMND
Employees4
IPO date2022-11-15
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.